Pcsa stock.

View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news from CNN.Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.Processa Pharmaceuticals Inc share price live 1.5566, this page displays NASDAQ PCSA stock exchange data. View the PCSA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Processa Pharmaceuticals Inc real time stock price chart below. You can find more …PCSA is the ticker symbol for Processa Pharmaceuticals Inc., a biotech company developing treatments for neurodegenerative diseases. The stock price, news, …

Processa Pharmaceuticals, Inc. (US:PCSA) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,620 shares.FREE delivery for orders over £50.00 ; RS Stock No.: 787-0314 ; Mfr. Part No.: 36.PCSA-1 ; Brand: ideal-tek ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...

May 6, 2024 · Rhea-AI Summary. Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has closed a public offering of 1,555,555 shares of common stock and common warrants, raising $7.0 million in gross proceeds. The offering price per share was $4.50, with the common warrants having an exercise price of $4.50 per share and a term of five years.

Find out the direct holders, institutional holders and mutual fund holders for Processa Pharmaceuticals, Inc. (PCSA).Processa Pharmaceuticals, Inc. had a return of -66.53% year-to-date (YTD) and -76.87% in the last 12 months. Over the past 10 years, Processa Pharmaceuticals, Inc. had an annualized return of -71.93%, while the S&P 500 had an annualized return of 10.89%, indicating that Processa Pharmaceuticals, Inc. did not perform as well as the …A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...

About. Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.

PCSA Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news ...

PCSA Stock Smart Score The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of ...morningstar.com - November 21 at 3:30 PM. Maxim Group Downgrades Processa Pharmaceuticals (PCSA) msn.com - November 18 at 7:47 AM. Processa Pharmaceuticals downgraded to Hold from Buy at Maxim. realmoney.thestreet.com - November 17 at 9:31 AM.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price...PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ...

You can find your newly purchased PCSA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets. Processa Pharmaceuticals Stock Earnings The value each PCSA share was expected to gain vs. the value that each PCSA share actually gained.Jan 26, 2024 ... The market value of their outstanding shares is at $4.9 million. Processa Pharma (NASDAQ:PCSA) stock declined by 28.63% to $3.64. The ...According to the announcement, PCSA common stock is slated to begin trading on a reverse stock split-adjusted basis at market opening on Jan. 22, 2024, under the same symbol: PCSA. The intention of the reverse stock split, the announcement noted, is for Processa Pharmaceuticals to regain compliance with the minimum bid price requirement of $1 ...Mountain. Loading Chart for PCSA. 9/21 12:03 PM. Previous Close 2.1300. Open 2.1100. Bid 2.0500 x 100. Ask 2.1100 x 200. Day's Range 2.0813 - 2.1900. 52 Week Range 1.4000 - 18.0000. Volume...May 16, 2024 1:36 AM ET Adial Pharmaceuticals, Inc. (ADIL) Stock By: Meghavi Singh, SA News Editor. Adial Pharmaceuticals press release ( NASDAQ: ADIL ): Q1 net …2 days ago · PCSA Earnings Date and Information. Processa Pharmaceuticals last posted its earnings data on March 29th, 2024. The reported ($0.24) EPS for the quarter. Processa Pharmaceuticals has generated ($4.95) earnings per share over the last year ( ($4.95) diluted earnings per share). Earnings for Processa Pharmaceuticals are expected to grow in the ...

May 6, 2024 · Rhea-AI Summary. Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has closed a public offering of 1,555,555 shares of common stock and common warrants, raising $7.0 million in gross proceeds. The offering price per share was $4.50, with the common warrants having an exercise price of $4.50 per share and a term of five years. PCSA's current price target is $8.00. Learn why top analysts are making this stock forecast for Processa Pharmaceuticals at MarketBeat.

It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...The above table shows the analyst PCSA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$2.09It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...In today’s fast-paced business world, effective stock management is crucial for any company that deals with software products. Software stock management refers to the process of ov...Jan 18, 2024 · Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304. Jan 18, 2024 ... Following the reverse stock split, the Company's common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with ...Get the latest stock price, quote, news and history of PCSA, a biotechnology company developing drugs for neurodegenerative diseases. See key data, market cap, data sources and more on Nasdaq.

4 days ago · PCSA is the ticker symbol for Processa Pharmaceuticals Inc., a biotech company developing treatments for neurodegenerative diseases. The stock price, news, analyst ratings, financials and other data are available on MarketWatch.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...

$2.1100. Previous Close- YTD Change. -68.77% 12 Month Change. -82.64% Day Range2.0800 - 2.1900.The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Monday, January 22, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.Learn more. PCS Technology Ltd Share Price Today - Get PCS Technology Ltd Share price LIVE on NSE/BSE and Price Chart, News, Announcements, Company Profile, Financial Statements, Company Holdings, Forecasts, Annual Reports and more!The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Monday, January 22, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.Get the latest Processa Pharmaceuticals, Inc. (PCSA) stock news and headlines to help you in your trading and investing decisions.Get Processa Pharmaceuticals Inc (PCSA.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ... View the latest Processa Pharmaceuticals Inc. (PCSA) stock price, news, historical charts, analyst ratings and financial information from WSJ.©2024 Processa Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Disclaimer Sitemap Manage Cookie Preferences. Market Data copyright © 2024 QuoteMedia.Data ...

PCS3117 for Pancreatic Cancer. On June 17, 2021, we entered into a licensing agreement with Ocuphire Pharma, Inc. (NASDAQ: OCUP) to license in RX-3117. RX-3117 is an oral, anticancer agent with an improved pharmacological profile relative to gemcitabine and other nucleoside analogs. Rx-3117 has a family of patents extending into 2036 as well as ...Processa Pharmaceuticals ( NASDAQ: PCSA) lost ~16% on Wednesday after the drug developer disclosed feedback it received from the FDA regarding a mid-stage trial for its chemotherapy candidate ...PCSA Stock Smart Score The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.Check out our PCSA stock analysis, current PCSA quote, charts, and historical prices for Processa Pharmaceuticals Inc stock Close Lightbox Download the free report here:Instagram:https://instagram. earn to die gamesound of a fanlax sfflghts to maui Processa Pharmaceuticals Stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for PCSA in the last 3 months. fll to bnaget rich or die tryin movie full movie How much insider buying is happening at Processa Pharmaceuticals? Insiders have purchased a total of 45,600 PCSA shares in the last 24 months for a total of $161,075.00 bought. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 5 nights at freddy's free games $2.1100. Previous Close- YTD Change. -68.77% 12 Month Change. -82.64% Day Range2.0800 - 2.1900.The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Monday, January 22, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “PCSA” with the new CUSIP number 74275C304.